These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30303139)
1. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver. Singha J; Khan K; Chatterjee S Indian J Pathol Microbiol; 2018; 61(4):510-515. PubMed ID: 30303139 [TBL] [Abstract][Full Text] [Related]
2. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver. Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Lin F; Abdallah H; Meschter S Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137 [TBL] [Abstract][Full Text] [Related]
5. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Wang L; Vuolo M; Suhrland MJ; Schlesinger K Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018 [TBL] [Abstract][Full Text] [Related]
6. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer. Agarwal A; Handa U; Kundu R; Sachdev A; Kochhar S J Cancer Res Ther; 2022 Dec; 18(Supplement):S434-S438. PubMed ID: 36510999 [TBL] [Abstract][Full Text] [Related]
7. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Borscheri N; Roessner A; Röcken C Am J Surg Pathol; 2001 Oct; 25(10):1297-303. PubMed ID: 11688465 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Chu PG; Ishizawa S; Wu E; Weiss LM Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703 [TBL] [Abstract][Full Text] [Related]
10. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor. Yoder M; Zimmerman RL; Bibbo M Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892 [TBL] [Abstract][Full Text] [Related]
11. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates. Gottschalk-Sabag S; Ron N; Glick T Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies. Zimmerman RL; Logani S; Baloch Z Diagn Cytopathol; 2005 Feb; 32(2):88-91. PubMed ID: 15637673 [TBL] [Abstract][Full Text] [Related]
13. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions. Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368 [TBL] [Abstract][Full Text] [Related]
14. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma. Wee A; Nilsson B Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration. Zimmerman RL; Burke M; Young NA; Solomides CC; Bibbo M Cancer; 2002 Feb; 96(1):53-7. PubMed ID: 11836704 [TBL] [Abstract][Full Text] [Related]
16. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. Röcken C; Licht J; Roessner A; Carl-McGrath S J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver. Ibrahim TR; Abdel-Raouf SM Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409 [TBL] [Abstract][Full Text] [Related]
18. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Morrison C; Marsh W; Frankel WL Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma. Li Y; Liu F; Zhou W; Zhang S; Chu P; Lin F; Wang HL Diagn Pathol; 2020 Oct; 15(1):127. PubMed ID: 33054843 [TBL] [Abstract][Full Text] [Related]
20. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates. Rishi M; Kovatich A; Ehya H Diagn Cytopathol; 1994 Dec; 11(4):358-61; discussion 361-2. PubMed ID: 7895575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]